Denali Therapeutics (DNLI) Cash & Equivalents (2017 - 2026)
Denali Therapeutics (DNLI) recorded Cash & Equivalents of $201.53 million in Q2 2026, up 42.7% from $141.21 million a year earlier but down 48.0% from the prior quarter.
Powered by 
Analysis
Denali Therapeutics (DNLI) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Denali Therapeutics reported Cash & Equivalents of $205.33 million, up 17.4% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -16.5% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $174.96 million in FY2024 (+37.6%), $127.11 million in FY2023 (-41.7%), $218.04 million in FY2022 (-25.7%) and $293.48 million in FY2021 (-42.1%).
- Quarterly Cash & Equivalents has ranged from $56.95 million in Q1 2025 to $394.55 million in Q3 2021 over the past five years.
- On a year-over-year basis, Cash & Equivalents has increased for five consecutive quarters, with growth averaging 90.4% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 580.7% in Q1 2026, against a decline of 75.9% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $387.63 million (Q1 2026), $205.33 million (Q4 2025) and $90.96 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Denali Therapeutics | 3.28 Bn | 3.28 Bn | 3.51 Mn | 201.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 201.53 Mn |
| Mar 31, 2026 | 387.63 Mn |
| Dec 31, 2025 | 205.33 Mn |
| Sep 30, 2025 | 90.96 Mn |
| Jun 30, 2025 | 141.21 Mn |
| Mar 31, 2025 | 56.95 Mn |
| Dec 31, 2024 | 174.96 Mn |
| Sep 30, 2024 | 90.64 Mn |
| Jun 30, 2024 | 74.68 Mn |
| Mar 31, 2024 | 60.57 Mn |
| Dec 31, 2023 | 127.11 Mn |
| Sep 30, 2023 | 148.01 Mn |
| Jun 30, 2023 | 131.97 Mn |
| Mar 31, 2023 | 68.13 Mn |
| Dec 31, 2022 | 218.04 Mn |
| Sep 30, 2022 | 118.62 Mn |
| Jun 30, 2022 | 155.09 Mn |
| Mar 31, 2022 | 104.95 Mn |
| Dec 31, 2021 | 293.48 Mn |
| Sep 30, 2021 | 394.55 Mn |
API Access
Denali Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=DNLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "DNLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=DNLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();